These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 18094050)

  • 1. MKKS is a centrosome-shuttling protein degraded by disease-causing mutations via CHIP-mediated ubiquitination.
    Hirayama S; Yamazaki Y; Kitamura A; Oda Y; Morito D; Okawa K; Kimura H; Cyr DM; Kubota H; Nagata K
    Mol Biol Cell; 2008 Mar; 19(3):899-911. PubMed ID: 18094050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutation analysis of the MKKS gene in McKusick-Kaufman syndrome and selected Bardet-Biedl syndrome patients.
    Slavotinek AM; Searby C; Al-Gazali L; Hennekam RC; Schrander-Stumpel C; Orcana-Losa M; Pardo-Reoyo S; Cantani A; Kumar D; Capellini Q; Neri G; Zackai E; Biesecker LG
    Hum Genet; 2002 Jun; 110(6):561-7. PubMed ID: 12107442
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ubiquitin ligase CHIP/STUB1 targets mutant keratins for degradation.
    Löffek S; Wöll S; Höhfeld J; Leube RE; Has C; Bruckner-Tuderman L; Magin TM
    Hum Mutat; 2010 Apr; 31(4):466-76. PubMed ID: 20151404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular genetics of Bardet-Biedl syndrome.
    Sheffield VC; Nishimura D; Stone EM
    Curr Opin Genet Dev; 2001 Jun; 11(3):317-21. PubMed ID: 11377969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel H395R mutation in MKKS/BBS6 causes retinitis pigmentosa and polydactyly without other findings of Bardet-Biedl or McKusick-Kaufman syndrome.
    Hulleman JD; Nguyen A; Ramprasad VL; Murugan S; Gupta R; Mahindrakar A; Angara R; Sankurathri C; Mootha VV
    Mol Vis; 2016; 22():73-81. PubMed ID: 26900326
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MKKS/BBS6, a divergent chaperonin-like protein linked to the obesity disorder Bardet-Biedl syndrome, is a novel centrosomal component required for cytokinesis.
    Kim JC; Ou YY; Badano JL; Esmail MA; Leitch CC; Fiedrich E; Beales PL; Archibald JM; Katsanis N; Rattner JB; Leroux MR
    J Cell Sci; 2005 Mar; 118(Pt 5):1007-20. PubMed ID: 15731008
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in MKKS cause obesity, retinal dystrophy and renal malformations associated with Bardet-Biedl syndrome.
    Katsanis N; Beales PL; Woods MO; Lewis RA; Green JS; Parfrey PS; Ansley SJ; Davidson WS; Lupski JR
    Nat Genet; 2000 Sep; 26(1):67-70. PubMed ID: 10973251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chaperone-dependent E3 ligase CHIP ubiquitinates and mediates proteasomal degradation of soluble guanylyl cyclase.
    Xia T; Dimitropoulou C; Zeng J; Antonova GN; Snead C; Venema RC; Fulton D; Qian S; Patterson C; Papapetropoulos A; Catravas JD
    Am J Physiol Heart Circ Physiol; 2007 Nov; 293(5):H3080-7. PubMed ID: 17873020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in MKKS cause Bardet-Biedl syndrome.
    Slavotinek AM; Stone EM; Mykytyn K; Heckenlively JR; Green JS; Heon E; Musarella MA; Parfrey PS; Sheffield VC; Biesecker LG
    Nat Genet; 2000 Sep; 26(1):15-6. PubMed ID: 10973238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. E3 ligase CHIP and Hsc70 regulate Kv1.5 protein expression and function in mammalian cells.
    Li P; Kurata Y; Maharani N; Mahati E; Higaki K; Hasegawa A; Shirayoshi Y; Yoshida A; Kondo T; Kurozawa Y; Yamamoto K; Ninomiya H; Hisatome I
    J Mol Cell Cardiol; 2015 Sep; 86():138-46. PubMed ID: 26232501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mkks-null mice have a phenotype resembling Bardet-Biedl syndrome.
    Fath MA; Mullins RF; Searby C; Nishimura DY; Wei J; Rahmouni K; Davis RE; Tayeh MK; Andrews M; Yang B; Sigmund CD; Stone EM; Sheffield VC
    Hum Mol Genet; 2005 May; 14(9):1109-18. PubMed ID: 15772095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutations in chaperonin-like BBS genes are a major contributor to disease development in a multiethnic Bardet-Biedl syndrome patient population.
    Billingsley G; Bin J; Fieggen KJ; Duncan JL; Gerth C; Ogata K; Wodak SS; Traboulsi EI; Fishman GA; Paterson A; Chitayat D; Knueppel T; Millán JM; Mitchell GA; Deveault C; Héon E
    J Med Genet; 2010 Jul; 47(7):453-63. PubMed ID: 20472660
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of expression of Bardet-Biedl syndrome proteins in the mammalian cochlea suggest noncentrosomal functions.
    May-Simera HL; Ross A; Rix S; Forge A; Beales PL; Jagger DJ
    J Comp Neurol; 2009 May; 514(2):174-88. PubMed ID: 19396898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A female with complete lack of Müllerian fusion, postaxial polydactyly, and tetralogy of fallot: genetic heterogeneity of McKusick-Kaufman syndrome or a unique syndrome?
    Slavotinek AM; Dutra A; Kpodzo D; Pak E; Nakane T; Turner J; Whiteford M; Biesecker LG; Stratton P
    Am J Med Genet A; 2004 Aug; 129A(1):69-72. PubMed ID: 15266619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CHIP functions an E3 ubiquitin ligase of Runx1.
    Shang Y; Zhao X; Xu X; Xin H; Li X; Zhai Y; He D; Jia B; Chen W; Chang Z
    Biochem Biophys Res Commun; 2009 Aug; 386(1):242-6. PubMed ID: 19524548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitination and degradation of mutant p53.
    Lukashchuk N; Vousden KH
    Mol Cell Biol; 2007 Dec; 27(23):8284-95. PubMed ID: 17908790
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective degradation of aggregate-prone CryAB mutants by HSPB1 is mediated by ubiquitin-proteasome pathways.
    Zhang H; Rajasekaran NS; Orosz A; Xiao X; Rechsteiner M; Benjamin IJ
    J Mol Cell Cardiol; 2010 Dec; 49(6):918-30. PubMed ID: 20863832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bardet-Biedl syndrome initially presenting as McKusick-Kaufman syndrome.
    Hou JW
    J Formos Med Assoc; 2004 Aug; 103(8):629-32. PubMed ID: 15340663
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CHIP promotes proteasomal degradation of familial ALS-linked mutant SOD1 by ubiquitinating Hsp/Hsc70.
    Urushitani M; Kurisu J; Tateno M; Hatakeyama S; Nakayama K; Kato S; Takahashi R
    J Neurochem; 2004 Jul; 90(1):231-44. PubMed ID: 15198682
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin-induced degradation of ErbB2: A role for the E3 ubiquitin ligase CHIP and the Michael reaction acceptor activity of curcumin.
    Jung Y; Xu W; Kim H; Ha N; Neckers L
    Biochim Biophys Acta; 2007 Mar; 1773(3):383-90. PubMed ID: 17239458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.